FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2783256086> ?p ?o ?g. }

• W2783256086 endingPage "99" @default.
• W2783256086 startingPage "88" @default.
• W2783256086 abstract "We previously identified the indole 264 as a potent in vitro antagonist of the human OXE receptor that mediates the actions of the powerful eosinophil chemoattractant 5-oxo-ETE. No antagonists of this receptor are currently commercially available or are being tested in clinical studies. The lack of a rodent ortholog of the OXE receptor has hampered progress in this area because of the unavailability of commonly used mouse or rat animal models. In the present study, we examined the feasibility of using the cynomolgus monkey as an animal model to investigate the efficacy of orally administered 264 in future in vivo studies. We first confirmed that 264 is active in monkeys by showing that it is a potent inhibitor of 5-oxo-ETE-induced actin polymerization and chemotaxis in granulocytes. The major microsomal metabolites of 264 were identified by cochromatography with authentic chemically synthesized standards and LC-MS/MS as its ω2-hydroxy and ω2-oxo derivatives, formed by ω2-oxidation of its hexyl side chain. Small amounts of ω1-oxidation products were also identified. None of these metabolites have substantial antagonist potency. High levels of 264 appeared rapidly in the blood following oral administration to both rats and monkeys, and declined to low levels by 24 h. As with microsomes, its major plasma metabolites in monkeys were ω2-oxidation products. We conclude that the monkey is a suitable animal model to investigate potential therapeutic effects of 264. This, or a related compound with diminished susceptibility to ω2-oxidation, could be a useful therapeutic agent in eosinophilic disorders such as asthma." @default.
• W2783256086 created "2018-01-26" @default.
• W2783256086 creator A5008842372 @default.
• W2783256086 creator A5022704926 @default.
• W2783256086 creator A5022813988 @default.
• W2783256086 creator A5028764377 @default.
• W2783256086 creator A5047553096 @default.
• W2783256086 creator A5052440022 @default.
• W2783256086 creator A5060846796 @default.
• W2783256086 creator A5064142865 @default.
• W2783256086 creator A5070022221 @default.
• W2783256086 creator A5081545783 @default.
• W2783256086 creator A5083960288 @default.
• W2783256086 date "2018-03-01" @default.
• W2783256086 modified "2023-10-17" @default.
• W2783256086 title "Metabolism and pharmacokinetics of a potent N-acylindole antagonist of the OXE receptor for the eosinophil chemoattractant 5-oxo-6,8,11,14-eicosatetraenoic acid (5-oxo-ETE) in rats and monkeys" @default.
• W2783256086 cites W1494579587 @default.
• W2783256086 cites W1540530514 @default.
• W2783256086 cites W1564740964 @default.
• W2783256086 cites W1586334166 @default.
• W2783256086 cites W1654089893 @default.
• W2783256086 cites W1684695949 @default.
• W2783256086 cites W1946388854 @default.
• W2783256086 cites W1969612042 @default.
• W2783256086 cites W1972594461 @default.
• W2783256086 cites W2034133667 @default.
• W2783256086 cites W2038572856 @default.
• W2783256086 cites W2052104184 @default.
• W2783256086 cites W2066882388 @default.
• W2783256086 cites W2069545704 @default.
• W2783256086 cites W2070095270 @default.
• W2783256086 cites W2070199322 @default.
• W2783256086 cites W2083856546 @default.
• W2783256086 cites W2125166909 @default.
• W2783256086 cites W2140048212 @default.
• W2783256086 cites W2141817909 @default.
• W2783256086 cites W2156326987 @default.
• W2783256086 cites W2170867229 @default.
• W2783256086 cites W2171057898 @default.
• W2783256086 cites W2325733949 @default.
• W2783256086 cites W2536022678 @default.
• W2783256086 cites W2562179046 @default.
• W2783256086 cites W2610348898 @default.
• W2783256086 cites W401798601 @default.
• W2783256086 doi "https://doi.org/10.1016/j.ejps.2018.01.021" @default.
• W2783256086 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29339225" @default.
• W2783256086 hasPublicationYear "2018" @default.
• W2783256086 type Work @default.
• W2783256086 sameAs 2783256086 @default.
• W2783256086 citedByCount "6" @default.
• W2783256086 countsByYear W27832560862018 @default.
• W2783256086 countsByYear W27832560862020 @default.
• W2783256086 countsByYear W27832560862021 @default.
• W2783256086 countsByYear W27832560862023 @default.
• W2783256086 crossrefType "journal-article" @default.
• W2783256086 hasAuthorship W2783256086A5008842372 @default.
• W2783256086 hasAuthorship W2783256086A5022704926 @default.
• W2783256086 hasAuthorship W2783256086A5022813988 @default.
• W2783256086 hasAuthorship W2783256086A5028764377 @default.
• W2783256086 hasAuthorship W2783256086A5047553096 @default.
• W2783256086 hasAuthorship W2783256086A5052440022 @default.
• W2783256086 hasAuthorship W2783256086A5060846796 @default.
• W2783256086 hasAuthorship W2783256086A5064142865 @default.
• W2783256086 hasAuthorship W2783256086A5070022221 @default.
• W2783256086 hasAuthorship W2783256086A5081545783 @default.
• W2783256086 hasAuthorship W2783256086A5083960288 @default.
• W2783256086 hasBestOaLocation W27832560862 @default.
• W2783256086 hasConcept C112705442 @default.
• W2783256086 hasConcept C150903083 @default.
• W2783256086 hasConcept C170493617 @default.
• W2783256086 hasConcept C185592680 @default.
• W2783256086 hasConcept C202751555 @default.
• W2783256086 hasConcept C203014093 @default.
• W2783256086 hasConcept C207001950 @default.
• W2783256086 hasConcept C2776042228 @default.
• W2783256086 hasConcept C2776885963 @default.
• W2783256086 hasConcept C2777037409 @default.
• W2783256086 hasConcept C2777477808 @default.
• W2783256086 hasConcept C54166955 @default.
• W2783256086 hasConcept C55493867 @default.
• W2783256086 hasConcept C57992300 @default.
• W2783256086 hasConcept C62231903 @default.
• W2783256086 hasConcept C86803240 @default.
• W2783256086 hasConcept C87644729 @default.
• W2783256086 hasConcept C98274493 @default.
• W2783256086 hasConceptScore W2783256086C112705442 @default.
• W2783256086 hasConceptScore W2783256086C150903083 @default.
• W2783256086 hasConceptScore W2783256086C170493617 @default.
• W2783256086 hasConceptScore W2783256086C185592680 @default.
• W2783256086 hasConceptScore W2783256086C202751555 @default.
• W2783256086 hasConceptScore W2783256086C203014093 @default.
• W2783256086 hasConceptScore W2783256086C207001950 @default.
• W2783256086 hasConceptScore W2783256086C2776042228 @default.
• W2783256086 hasConceptScore W2783256086C2776885963 @default.
• W2783256086 hasConceptScore W2783256086C2777037409 @default.
• W2783256086 hasConceptScore W2783256086C2777477808 @default.
• W2783256086 hasConceptScore W2783256086C54166955 @default.
• W2783256086 hasConceptScore W2783256086C55493867 @default.

• next